key: cord-0806091-g29ejr2b
authors: Karbalaei, Mohsen; Rezaee, Seyed A.; Farsiani, Hadi
title: Pichia pastoris: A highly successful expression system for optimal synthesis of heterologous proteins
date: 2020-02-14
journal: J Cell Physiol
DOI: 10.1002/jcp.29583
sha: 44603146f1962a91da062ec4f305ec7dc1bb0307
doc_id: 806091
cord_uid: g29ejr2b

One of the most important branches of genetic engineering is the expression of recombinant proteins using biological expression systems. Nowadays, different expression systems are used for the production of recombinant proteins including bacteria, yeasts, molds, mammals, plants, and insects. Yeast expression systems such as Saccharomyces cerevisiae (S. cerevisiae) and Pichia pastoris (P. pastoris) are more popular. P. pastoris expression system is one of the most popular and standard tools for the production of recombinant protein in molecular biology. Overall, the benefits of protein production by P. pastoris system include appropriate folding (in the endoplasmic reticulum) and secretion (by Kex2 as signal peptidase) of recombinant proteins to the external environment of the cell. Moreover, in the P. pastoris expression system due to its limited production of endogenous secretory proteins, the purification of recombinant protein is easy. It is also considered a unique host for the expression of subunit vaccines which could significantly affect the growing market of medical biotechnology. Although P. pastoris expression systems are impressive and easy to use with well‐defined process protocols, some degree of process optimization is required to achieve maximum production of the target proteins. Methanol and sorbitol concentration, Mut forms, temperature and incubation time have to be adjusted to obtain optimal conditions, which might vary among different strains and externally expressed protein. Eventually, optimal conditions for the production of a recombinant protein in P. pastoris expression system differ according to the target protein.

cell factory has some limitations such as intracellular aggregation and misfolding of heterologous proteins, production of lipopolysaccharide, lack of posttranslational modification, and protein degradation due to proteases (Rosano & Ceccarelli, 2014) (Khan, 2013) .

Besides, mammalian expression systems grow slowly and the relevant nutrient requirement is costly. On the other hand, potential contamination of culture medium with some viruses has limited its use in large-scale production (Yin, Li, Ren, & Herrler, 2007) . Yeasts are other eukaryotic cells that are widely used for the expression of several proteins in vaccine and pharmaceutical production. The mechanism of protein expression in these microorganisms is close to the ones in mammalian cells. Compared with bacteria, yeast cells have significant advantages including growth speed, posttranslational modification, secretory expression, and easy genetic manipulation. Furthermore, linearized foreign DNA can be inserted in a chromosome in high efficiency via cross recombination phenomena to generate stable cell lines (Daly & Hearn, 2005) . Among yeast cells, Saccharomyces cerevisiae is used in the manufacture of hepatitis B and human papillomavirus vaccines, both of which produce a protective immune response against wild-type viruses (Bill, 2015) . The expression proteins in S. cerevisiae are often N and O-hyperglycosylated, which may affect protein immunogenicity (Rasala & Mayfield, 2015) .

In recent years, to solve the problem of protein expression, methylotrophic yeasts such as Hansenulla polymorpha and Pichia pastoris (P. pastoris; syn. Komagataella phaffii) have been developed.

Among these, P. pastoris has become the most popular for its cost and expression host system. This microorganism can produce high yields of recombinant proteins with the high similarity of glycosylation to the mammalian cells (Balamurugan, Reddy, & Suryanarayana, 2007) .

Overall, the benefits of protein production by P. pastoris system include appropriate folding (in the endoplasmic reticulum [ER] ) and secretion (by Kex2 as signal peptidase) of recombinant proteins to the external environment of the cell (S. Yang et al., 2013) . Given the fact that some proteins produced by their original host are secreted out of the cell; P. pastoris is suitable for the production of recombinant proteins since it is equipped with a secretion system (Ahmad, Hirz, Pichler & Schwab, 2014) . The basic characteristics of different host systems for the expression of recombinant proteins are summarized in Table 1 .

Historically, P. pastoris yeast was first isolated from the exudates of a chestnut tree in France and was named Zygosaccharomyces pastoris by Guilliermond (Zahrl, Peña, Mattanovich, & Gasser, 2017) . Yamada et al. then categorized the organism to a novel genus, Komagataella or Pichia (Naumov, Naumova, & Boundy-Mills, 2018) . It has been proven that P. pastoris, as an engineered methylotrophic microorganism, can use methanol as sole carbon and energy source (Cereghino, Cereghino, Ilgen & Cregg, 2002) . Unlike, Y-11430 strain (wild-type), which is not used for protein expression, GS115 is one of the most popular strains used as an important expression system particularly in industry and medicine fields (Julien, 2006) . P. pastoris GS115 strain has two encoding genes (AOX1 and AOX2) of alcohol oxidase (AOX) enzyme. In the presence of methanol, the transcription of these genes is induced and finally produces a high amount of AOX enzyme (Vanz et al., 2012) . Although both genes are used for the production of an AOX enzyme, AOX1 produces more enzyme. Therefore, by knocking out the AOX1 gene, the growth on methanol is slowed down drastically. This phenotype is called methanol utilization slow (Mut S ).

A knockout of the AOX2 gene will not decelerate growth on methanol Cámara et al., 2017) . In the KM71 strain, as a derivative of GS115, aox1 gene has been deleted; therefore, this strain is known as Mut S strain (Charoenrat et al., 2013) . Older strains such as KM7121, MC100-3, and MC101-1, cannot use methanol as a food source (Mut − ), because no AOX genes were detected in these strains and therefore they were unable to grow in the presence of methanol (Cregg, Madden, Barringer, Thill, & Stillman, 1989) .

3 | THE CHARACTERISTIC FEATURES OF P. pastoris EXPRESSION SYSTEM 3.1 | Advantages and drawbacks of the P. pastoris expression system

Pichia expression system has advantages for the expression of different recombinant proteins. As noted, P. pastoris is a methylotrophic yeast which is known as a recombinant expression host system. One of the advantages of the Pichia system is its high similarity with advanced eukaryotic expression systems such as CHO cell lines. This yeast system is inexpensive, it also has relatively rapid expression times, cotranslational and posttranslational processing.

By the use of industrial bioreactors, proteins of interest can be produced on a large scale from small culture volumes. Recently, studies have shown that the Pichia expression system is unique in the production of membrane proteins including calcium and potassium channels, nitrate and phosphate transporter, and histamine H1 receptor (Byrne, 2015) . Furthermore, P. pastoris is a suitable microorganism in the secretory production of recombinant proteins directly into the supernatant of the culture medium. In the P. pastoris expression system due to its limited production of endogenous secretory proteins, the purification of recombinant protein is easy (Tachioka et al., 2016) .

Another advantage of P. pastoris as a protein production host is its ability to perform posttranslational modifications such as O-and N-linked glycosylation and disulfide bond formation. Many therapeutic proteins are glycoproteins and require the attachment of carbohydrate structures to the protein backbone (glycosylation) to allow for correct folding, solubility, stability, and proper biological activity (Cereghino et al., 2002) . There are two main types of glycosylation in been observed in P. pastoris (Bretthauer & Castellino, 1999) . Due to its attractive characteristics for heterologous protein production (low incidence of hyperglycosylation), P. pastoris is an interesting organism for the production of therapeutic glycoproteins. The N-glycosylation plays an important role in achieving complete biological activities of therapeutic proteins such as interferon, erythropoietin, and monoclonal antibodies. The N-glycosylation pathway in mammalian cells

consists of the addition of one or more N-acetylglucosamine (GlcNAc) residues followed by the sequential addition of galactose (Gal) and

sialic acid which creates a complex type of N-glycans ( Figure 1a ).

While, hypermannosylation of recombinant protein in the P. pastoris 

However, like other expression systems, this eukaryotic system has some disadvantages. In the transformation stage, unlike the bacterial system, competent cells require large (µg-level) amounts of the plasmid.

The number of E. coli transformants (10 8 -10 11 ) is higher than P. pastoris transformants (10 3 -10 4 ) per µg of DNA (S. Wu & Letchworth, 2004) .

The production of recombinant protein in this system is regulated through two promoters: Promoter of glyceraldehyde-3-phosphate dehydrogenase (P GAP ) and promoter of AOX (P AOX1 ). Despite several F I G U R E 1 Schematic diagram of N-linked glycan structure in a mammalian cell, Saccharomyces cerevisiae and, Pichia pastoris. (a) N-linked glycan structure in mammalian cells commonly generates complex terminally sialylated structures. (b) In S. cerevisiae, the N-linked glycan structure is typically hypermannosylated (Man > 50GlcNAc2). Moreover, S. cerevisiae core oligosaccharides have terminal α-1,3 glycan linkages.

(c) N-linked glycan structure in P. pastoris typically is of the Man8-14GlcNAc2 type with a triantennary-branched structure. Unlike S. cerevisiae, P. pastoris does not contain potentially immunogenic terminal α-1,3-linked mannoses. (d) In Pichia GlycoSwitch® strains (SuperMan5) N-linked glycan structure is typically hypomannosylated (with a mannose-5 structure)

advantages, both promoters have no tenability (Rajamanickam, Metzger, Schmid, & Spadiut, 2017) . Protein production in yeast systems is dependent on the consumption of methanol. Based on EasySelect™ Pichia Expression Kit (Catalog no. K1750-01, Invitrogen, Carlsbad, CA), at least 0.5% concentration of methanol is required for the expression of recombinant proteins. The production could reach to the maximum level of 2-2.5% (wt/vol) of methanol (Z. Wang et al., 2010) . Normally, the concentration of methanol up to 5% is tolerable for the organisms, but high levels of methanol concentrations (above 5%) are very toxic for cell viability and can stop the production process (Santoso, Herawati, & Rubiana, 2012) . Another limitation in the Pichia system is the presence of a few selectable markers for P. pastoris transformation. Selectable marker genes include his4, arg4, and Shble (needed to resist against Zeocin antibiotic) (Cereghino & Cregg, 1999) . A common occurrence in this system is the contamination of expressive broth culture with saprophytic bacteria and fungi. The secreted proteases of these microorganisms potentially hydrolyze the secreted proteins to the supernatant (Stewart, 2015) . Indeed, one of the problems in the P. pastoris expression system is the destruction of proteins produced by proteases. New P. pastoris strains such as SMD1163 (his4 pep4 prb1), SMD1165 (his4 pep4), SMD1168 (his4 pep4), BG21, and Pichia pink have no protease; therefore, the degradation of a secreted protein is prevented. In these strains, to achieve high product yields and the quality of recombinant proteins, the genes encoding of proteinase A (pep4) and proteinase B (prb1) have been disrupted (Safder, Khan, Islam, & Kazim, 2018) .

3.2 | General topics for cloning and expression in P. pastoris β-Galactosidase H. Sun et al. (2017) pJL-IX FLD1, Amp MS105 Formaldehyde dehydrogenase Sunga and Cregg (2004) pBLHIS-IX His4, Amp KM71 L1-L2 proteins of HPV virus type 16 Bredell, Smith, Görgens, and van Zyl (2018) Abbreviation: HPV, human papillomavirus.

Also, for the production of recombinant subunit vaccines, P. pastoris is more famous than other expression systems . Subunit vaccines often suffer from poor immunogenicity and require certain helper molecules known as adjuvants to induce or enhance an appropriate immune response to the antigen.

T-cell activation is crucial in inducing protective immune responses (Todryk, 2018) . Antigens mannosylated by P. pastoris have shown to have enhanced antigen presentation and T-cell activation properties compared with their nonglycosylated counterparts. Therefore, glycoproteins derived from P. pastoris have the potential to function as adjuvants. The increased immunogenicity of mannosylated glycoproteins is thought to be linked to certain mannose-binding receptors carried by professional antigen-presenting cells, like dendritic cells and macrophages (Luong, Lam, Chen, & Levitz, 2007) .

Some of the new recombinant subunit vaccines that have been expressed in P. pastoris system are listed in Table 4 .

Methanol and sorbitol concentration, Mut forms, temperature and incubation time have to be adjusted to obtain optimal conditions, which might vary among different strains and externally expressed protein.

Methanol is the principal carbon source and gene expression induction agent in most P. pastoris fermentation strategies.

Monitoring methanol levels during fermentation enables cell growth and optimizes productivity, whilst methanol toxicity is avoided. Methanol is used for both biomass growth and the production of protein in P. pastoris. Based on the utilization of methanol, P. pastoris strains are divided into three phenotypes:

Mut + strains with both AOX1 and AOX2 genes in their chromosomes; Mut S strains with only AOX2 gene; and Mut − mutant strains without any AOX genes (Anggiani, Helianti, & Abinawanto, 2018 heterologous proteins, which results in lower productivity (W. Zhang, Bevins, Plantz, Smith, & Meagher, 2000) . The optimum methanol concentration used in some research articles is listed in Table 5 .

In the P. pastoris expression system, one of the most well-known carbon sources which can be used with methanol is sorbitol. Sorbitol does not induce or repress AOX promoters, hence using sorbitol instead of glycerol in mixed substrate methods could reduce cell growth rate, and increase specific product formation rates. The use of mixed substrates increases productivity and cell density and reduces induction time (Orman, Calik, & Ozdamar, 2009 ). Moreover, cofeeding of sorbitol with methanol reduces the toxic effects of intermediate metabolites and oxygen consumption. However, sorbitol has a negative impact on the specific activity of the AOX1 promoter (Çelik, Çalık, & Oliver, 2009) . Several studies revealed that methanol/sorbitol cofeeding increases the expression of the recombinant proteins (Gao et al., 2012; Z. Wang et al., 2010; T. Zhu et al., 2011) . The results obtained by Azadi, Mahboubi, Naghdi, Solaimanian, and Mortazavi (2017) showed that sorbitol at a concentration of 50 g/L (5%) could significantly increase the expression of recombinant protein. Moreover, according to the results of other studies, 2.5% methanol with 1% sorbitol , 2% methanol with 0.5% sorbitol , and 2% methanol with 1% sorbitol (Soleimanpour et al., 2015) were considered optimal for the highest recombinant protein production in shake flask culture. Therefore, the presence of other carbon sources such as glycerol and sorbitol can be beneficial to increase protein production. Since the AOX1 promoter is repressed severely by glycerol, sorbitol is considered an appropriate replacement (M. Gao & Shi, 2013) .

The required growth temperature for P. pastoris is 28-30°C.

Temperatures above 32°C could be detrimental to protein expression induction and can even cause cell death. Several studies revealed that by lowering the cultivation temperature from 30°C to 20°C, protein production can be improved according to higher yeast cell viability, decreased folding stress and lower proteolytic activity against the target protein (Dragosits et al., 2009; Gao et al., 2015; Gasser et al., 2007; Li et al., 2001; Zhong et al., 2014) . The decreased synthetic rate of target protein in low-temperature cultivation causes ER stress reduction, preserves the folding capacity of the ER and enhances cell viability (Zhong et al., 2014) .

Incubation time is one of the most critical factors for acquiring the highest protein expression level in the P. pastoris expression system. In the P. pastoris expression system, production time is relatively long (about 100 hr). The incubation time is related to the number of yeast cells and the degree of target protein degradation. Santoso et al. (2012) showed that the highest growth of P. pastoris cells was at 96 hr incubation time, whereas the highest protein expression occurred at 48 hr. This suggests that it is very possible that longer incubation time may cause more proteolytic digestion of the expressed protein. Moreover, other studies discussed that optimal protein expression occurred at 72 to 96 hr incubation time Soleimanpour et al., 2015) .

The P. pastoris has also been established as a versatile cell factory for the production of thousands of biomolecules both on a laboratory and industrial scale. Some of the new recombinant biological molecules that have been expressed in the P. pastoris system are listed in Table 6 . 

For the production of recombinant proteins with medical and industrial purposes, researchers should apply biological expression systems. Yeast expression systems such as S. cerevisiae and P. pastoris are more popular. P. pastoris expression system is one of the most popular and standard tools for the production of recombinant protein in molecular biology. It is also considered a unique host for the expression of subunit vaccines which could significantly affect the growing market of medical biotechnology. Although P. pastoris expression systems are impressive and easy to use with welldefined process protocols, some degree of process optimization is required to achieve maximum production of the target proteins.

Eventually, optimal conditions for the production of a recombinant protein in P. pastoris expression system differ according to the target protein.

The authors declare that there are no conflict of interests.

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Abbreviations: hIFN-γ, human interferon γ; IL, interleukin; NK, natural killer.

Protein expression in Pichia pastoris: Recent achievements and perspectives for heterologous protein production

Optimization of methanol induction for expression of synthetic gene Thermomyces lanuginosus lipase in Pichia pastoris

High-level expression of non-glycosylated and active staphylokinase from Pichia pastoris

Construction of new Pichia pastoris X-33 strains for production of lycopene and β-carotene

Evaluation of sorbitol-methanol co-feeding strategy on production of recombinant human growth hormone in Pichia pastoris

Molecular optimization of rabies virus glycoprotein expression in Pichia pastoris

Expression and purification of C-peptide containing insulin using Pichia pastoris expression system

CFP10: MFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouse

Pichia pastoris: A notable heterologous expression system for the production of foreign proteins-vaccines

Biotechnology in the production of recombinant vaccine or antigen for animal health

Recombinant protein expression in Escherichia coli

Cloning and expression of human ribonuclease 4 in methylotrophic yeast Pichia pastoris

Recombinant protein subunit vaccine synthesis in microbes: A role for yeast?

Expression of unique chimeric human papilloma virus type 16 (HPV-16) L1-L2 proteins in Pichia pastoris and Hansenula polymorpha

Glycosylation of Pichia pastorisderived proteins

Pichia pastoris as an expression host for membrane protein structural biology

Production of the active antifungal Pisum sativum defensin 1 (Psd1) in Pichia pastoris: Overcoming the inefficiency of the STE13 protease

Increased dosage of AOX1 promoter-regulated expression cassettes leads to transcription attenuation of the methanol metabolism in Pichia pastoris

Characterization of a panARS-based episomal vector in the methylotrophic yeast Pichia pastoris for recombinant protein production and synthetic biology applications

Fed-batch methanol feeding strategy for recombinant protein production by Pichia pastoris in the presence of co-substrate sorbitol

Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris

Applications of yeast in biotechnology: Protein production and genetic analysis

Expression of recombinant Arabian camel lactoferricin-related peptide in Pichia pastoris and its antimicrobial identification

Expression of stable and active human DNA topoisomerase I in Pichia pastoris

Improvement of recombinant endoglucanase produced in Pichia pastoris KM71 through the use of synthetic medium for inoculum and pH control of proteolysis

Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate

Highlevel heterologous production and functional secretion by recombinant Pichia pastoris of the shortest proline-rich antibacterial honeybee peptide Apidaecin

High-level expression of a novel Penicillium endo-1, 3 (4)-β-Dglucanase with high specific activity in Pichia pastoris

Recombinant antimicrobial peptide hPAB-β expressed in Pichia pastoris, a potential agent active against methicillin-resistant Staphylococcus aureus

Functional characterization of the two alcohol oxidase genes from the yeast Pichia pastoris

Improvement of bread making quality by supplementation with a recombinant xylanase produced by Pichia pastoris

High level production of active streptokinase in Pichia pastoris fed-batch culture

Combined effect of gene dosage and process optimization strategies on high-level production of recombinant human interleukin-3 (hIL-3) in Pichia pastoris fed-batch culture

Expression of heterologous proteins in Pichia pastoris: A useful experimental tool in protein engineering and production

Cloning and high-level expression of β-xylosidase from Selenomonas ruminantium in Pichia pastoris by optimizing of pH, methanol concentration and temperature conditions

Chicken IgY Fc linked to Bordetella avium ompA and Taishan Pinus massoniana pollen polysaccharide adjuvant enhances macrophage function and specific immune responses

The effect of temperature on the proteome of recombinant Pichia pastoris

Production of recombinant human epidermal growth factor in Pichia pastoris

High-level expression of a biologically active staphylokinase in Pichia pastoris

Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6: CFP-10 complex

High expression of recombinant Streptomyces sp. S38 xylanase in Pichia pastoris by codon optimization and analysis of its biochemical properties

Methanol/sorbitol co-feeding induction enhanced porcine interferon-alpha production by P. pastoris associated with energy metabolism shift

Process control and optimization for heterologous protein production by methylotrophic Pichia pastoris

Improving performance and operational stability of porcine interferon-α production by Pichia pastoris with combinational induction strategy of low temperature and methanol/sorbitol cofeeding

Monitoring of transcriptional regulation in Pichia pastoris under protein production conditions

Expression, purification and in vitro enzyme activity assay of plant derived GTPase

An overview of heterologous expression host systems for the production of recombinant proteins

High-level expression and stabilization of recombinant human chitinase produced in a continuous constitutive Pichia pastoris expression system

A comparative study of maltooligosyltrehalose synthase from Sulfolobus acidocaldarius expressed in Pichia pastoris and Escherichia coli

High-level expression of recombinant bovine lactoferrin in Pichia pastoris with antimicrobial activity

Pichia pastoris, Production of recombinant proteins-Novel microbial and eukaryotic expression systems

Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology

Functional expression of a thermostable Endoglucanase from Thermoascus aurantiacus RCKK in Pichia pastoris X-33 and its characterization

High-level extracellular production of Rhizopus oryzae lipase in Pichia pastoris via a strategy combining optimization of gene-copy number with co-expression of ERAD-related proteins

Production of humanlike recombinant proteins in Pichia pastoris

Expression of the full-length human recombinant keratinocyte growth factor in Pichia pastoris

Expression of recombinant Newcastle disease virus F protein in Pichia pastoris and its immunogenicity using flagellin as the adjuvant

Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis

Gene expression in mammalian cells and its applications

Recombinant dengue virus 4 envelope glycoprotein virus-like particles derived from Pichia pastoris are capable of eliciting homotypic domain III-directed neutralizing antibodies

Expression, purification and characterization of the recombinant cysteine-rich antimicrobial peptide snakin-1 in Pichia pastoris

Enhanced expression of human prostaglandin H synthase-2 in the yeast Pichia pastoris and removal of the C-terminal tag with bovine carboxypeptidase A

Production in Pichia pastoris, antifungal activity and crystal structure of a class I chitinase from cowpea (Vigna unguiculata): Insights into sugar binding mode and hydrolytic action

Engineering the Pichia pastoris N-glycosylation pathway using the GlycoSwitch Technology

Auto-induction of Pichia pastoris AOX1 promoter for membrane protein expression

Expression and characterization of monomeric variable lymphocyte receptor B specific to the glycoprotein of viral hemorrhagic septicemia virus (VHSV)

Recent advances of vaccine adjuvants for infectious diseases

Expression of recombinant tachyplesin I in Pichia pastoris

Expression of recombinant proteins in Pichia pastoris

An improved method for enhanced production and biological activity of human secretory leukocyte protease inhibitor (SLPI) in Pichia pastoris

Construction of efficient xylose utilizing Pichia pastoris for industrial enzyme production

Optimization of the secretory expression of recombinant human C-reactive protein in Pichia pastoris

High level expression, purification, and characterization of the shrimp antimicrobial peptide, Ch-penaeidin, in Pichia pastoris

Low-temperature increases the yield of biologically active herring antifreeze protein in Pichia pastoris

High-level secretory expression and purification of recombinant human interleukin 1 beta in Pichia pastoris

Production of a recombinant carrot antifreeze protein by Pichia pastoris GS115 and its cryoprotective effects on frozen dough properties and bread quality

Expression and antibacterial activity of hybrid antimicrobial peptide cecropinA-thanatin in Pichia pastoris

Cultivation strategies to enhance productivity of Pichia pastoris: A review

Combining expression and process engineering for high-quality production of human sialyltransferase in Pichia pastoris

Heterologous expression of the plant cysteine protease bromelain and its inhibitor in Pichia pastoris

Effects of fungal N-and O-linked mannosylation on the immunogenicity of model vaccines

Heterologous protein production using the Pichia pastoris expression system

A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection

Expression, purification and characterization of a recombinant antimicrobial peptide Hispidalin in Pichia pastoris

Scedosporium boydii CatA1 and SODC recombinant proteins, new tools for serodiagnosis of Scedosporium infection of patients with cystic fibrosis

Live attenuated vaccines: Historical successes and current challenges

Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine

Description of Komagataella mondaviorum sp. nov., a new sibling species of Komagataella (Pichia) pastoris

Expression of a novel adjuvant TFPR1 in Pichia pastoris and its identification

High-level production of human type I collagen in the yeast Pichia pastoris

Increasing gene dosage greatly enhances recombinant expression of aquaporins in Pichia pastoris

The influence of carbon sources on recombinant-human-growth-hormone production by Pichia pastoris is dependent on phenotype: A comparison of Muts and Mut + strains

Production of chimeric acidic α-amylase by the recombinant Pichia pastoris and its applications

Patents in therapeutic recombinant protein production using mammalian cells

Biotechnological production of the cell penetrating antifungal PAF102 peptide in Pichia pastoris

Improving the production of human interferon gamma (hIFN-γ) in Pichia pastoris cell factory: An approach of cell level

Expression of nitrile hydratase gene of mutant 4D strain of Rhodococcus rhodochrous PA 34 in Pichia pastoris

A novel bi-directional promoter system allows tunable recombinant protein production in Pichia pastoris

Expression of a novel recombinant cyanate hydratase (rTl-Cyn) in Pichia pastoris, characteristics and applicability in the detoxification of cyanate

Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses

Is Pichia pastoris a realistic platform for industrial production of recombinant human interferon gamma?

Recombinant protein expression in Escherichia coli: Advances and challenges

Pichia pastoris expression system: A potential candidate to express protein in industrial and biopharmaceutical domains

Constitutive expression of human gastric lipase in Pichia pastoris and site-directed mutagenesis of key lid-stabilizing residues

Effect of methanol induction and incubation time on expression of human erythropoietin in methylotropic yeast Pichia pastoris

Expression and characterization of yeast derived Chikungunya virus like particles (CHIK-VLPs) and its evaluation as a potential vaccine candidate

Generation of a functionally distinct Rhizopus oryzae lipase through protein folding memory

Raising expectations for subunit vaccine

APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice

Optimization of a multi-stage, multi-subunit malaria vaccine candidate for the production in Pichia pastoris by the identification and removal of protease cleavage sites

Yeast quality assessment, management and culture maintenance, Brewing Microbiology

Systematic assessment of Pichia pastoris system for optimized β-galactosidase production

High level expression and purification of active recombinant human interleukin-15 in Pichia pastoris

The Pichia pastoris formaldehyde dehydrogenase gene (FLD1) as a marker for selection of multicopy expression strains of P. pastoris

Development of simple random mutagenesis protocol for the protein expression system in Pichia pastoris

Immunogenicity of heparinbinding hemagglutinin expressed by Pichia pastoris GS115 strain

T cell memory to vaccination. Vaccines

Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies

Extracellular expression and antiviral activity of a bovine interferonalpha through codon optimization in Pichia pastoris

Highlevel expression and immunogenicity of a porcine circovirus type 2 capsid protein through codon optimization in Pichia pastoris

Functional expression of recombinant goat chymosin in Pichia pastoris bioreactor cultures: A commercially viable alternate

A recombinant human anti-platelet SCFV antibody produced in Pichia pastoris for atheroma targeting

Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the Hepatitis B surface antigen: Catabolic adaptation, stress responses, and autophagic processes

Heterologous expression of the antimyotoxic protein DM64 in Pichia pastoris

Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus

Recent advances in the production of recombinant subunit vaccines in Pichia pastoris

Efficient production of recombinant glycoprotein D of herpes simplex virus type 2 in Pichia pastoris and its protective efficacy against viral challenge in mice

Fused IgY Fc and polysaccharide adjuvant enhanced the immune effect of the recombinant VP2 and VP5 subunits-A prospect for improvement of infectious bursal disease virus subunit vaccine

Methanol-independent protein expression by AOX1 promoter with trans-acting elements engineering and glucose-glycerol-shift induction in Pichia pastoris

High level expression and glycosylation of recombinant Mycobacterium tuberculosis Ala-Pro-rich antigen in Pichia pastoris

Enhancement of cell viability and alkaline polygalacturonate lyase production by sorbitol co-feeding with methanol in Pichia pastoris fermentation

Heterologous expression of three Camellia sinensis small heat shock protein genes confers temperature stress tolerance in yeast and Arabidopsis thaliana

Recombinant botulinum neurotoxin Hc subunit (BoNT Hc) and catalytically inactive Clostridium botulinum holoproteins (ciBoNT HPs) as vaccine candidates for the prevention of botulism

Constitutive and secretory expression of the AiiA in Pichia pastoris inhibits Amorphophallus konjac soft rot disease

High efficiency transformation by electroporation of Pichia pastoris pretreated with lithium acetate and dithiothreitol

Engineering of a Pichia pastoris expression system for high-level secretion of HSA/GH fusion protein

Recombinant expression and biological characterization of the antimicrobial peptide fowlicidin-2 in Pichia pastoris

Enhanced production of recombinant secretory proteins in Pichia pastoris by optimizing Kex2 P1'site

Expression of recombinant transglutaminase gene in Pichia pastoris and its uses in restructured meat products

Select what you need: A comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes

Core-shell protein clusters comprising haemoglobin and recombinant feline serum albumin as an artificial O2 carrier for cats

Efficient expression and isolation of recombinant human interleukin-11 (rhIL-11) in Pichia pastoris

Systems biotechnology for protein production in Pichia pastoris

Modeling Pichia pastoris growth on methanol and optimizing the production of a recombinant protein, the heavy-chain fragment C of botulinum neurotoxin, serotype A

High-yield secretory production of stable, active trypsin through engineering of the N-terminal peptide and self-degradation sites in Pichia pastoris

High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice

Protective immunity induced by the vaccination of recombinant Proteus mirabilis OmpA expressed in Pichia pastoris

Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus

Functional recombinant human Legumain protein expression in Pichia pastoris to enable screening for Legumain small molecule inhibitors

Characterization of bioactive recombinant antimicrobial peptide parasin I fused with human lysozyme expressed in the yeast Pichia pastoris system

High-temperature cultivation of recombinant Pichia pastoris increases endoplasmic reticulum stress and decreases production of human interleukin-10

High level expression and purification of recombinant human serum albumin in Pichia pastoris

Combinatorial strategy of sorbitol feeding and low-temperature induction leads to high-level production of alkaline betamannanase in Pichia pastoris

Heterologous expression and characterization of three laccases obtained from Pleurotus ostreatus HAUCC 162 for removal of environmental pollutants

Pichia pastoris: A highly successful expression system for optimal synthesis of heterologous proteins